DZD9008
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for DZD9008, covering 2024-05-29 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28) [Phase 3]